FDA Inspection
AJENAT PHARMACEUTICALS LLCAJENAT PHARMACEUTICALS LLC – FDA Inspection, Sep 24, 2026
Record Details
This FDA Inspection record concerns AJENAT PHARMACEUTICALS LLC, with an inspection on September 24, 2026, issued by the Florida District Office, covering animal drugs & feeds.
View Company Profile
ID · 9f4d267e-4b2a-4a82-83fb-97eb23fdbc30
Inspection Facts
- Inspection number
- 1337342
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.84(a)Components withheld from use pending release
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AJENAT PHARMACEUTICALS LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | Not classified | Florida District Office | |
| August 16, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AJENAT PHARMACEUTICALS LLC
- FDA Inspection 1262754 - 2025-02-07
- FDA Inspection 1246567 - 2024-08-16
- FDA Inspection 1093582 - 2019-05-24
- FDA Inspection 1042674 - 2018-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.